Join us for our webinar, where we'll focus on miRNA data analysis using QIAGEN CLC Genomics Workbench and Biomedical Genomics Analysis plugin. Together, we'll explore how you can:
• Import reads and metadata
• Download miRBase database
• Quantify miRNA expression
• Perform differential expression analysis
• Visualize your results
• Create and use a custom database
Bring any questions you may have, and we will answer them during the webinar.
In this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functions, tissues and cell types.
We’ll cover topics such as:
- How to analyze miRNA-seq datasets alone, or both miRNA and corresponding mRNA datasets together
- How to use QIAGEN IPA without a dataset, using miRNA IDs
- Introduction to databases and curated content specific to miRNA
- How to effectively apply various filters and functionalities to identify biomarkers, key targets and novel biological mechanisms
In this webinar, we will introduce how to analyze and explore your QIAseq miRNA data in RNA-seq Analysis Portal.
During the webinar, we will answer the following questions: • Which sample kits are supported by RNA-seq Analysis Portal? • How to upload your data to RNA-seq Analysis Portal? • How to start an analysis? • How to create a project? • How to create an experiment for differential expression? • How to inspect your experiment and quality control of your dataset? • How to view and filter differential expression results? • How to export your results?
Bring any questions you may have and we will answer them during the webinar.
In this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functions, tissues and cell types.
We’ll cover topics such as:
- How to analyze miRNA-seq datasets alone, or both miRNA and corresponding mRNA datasets together
- How to use QIAGEN IPA without a dataset, using miRNA IDs
- Introduction to databases and curated content specific to miRNA
- How to effectively apply various filters and functionalities to identify biomarkers, key targets and novel biological mechanisms
Each month we’re hosting a series of webinars introducing Ingenuity Pathway Analysis.
The first webinar each month is giving you an introduction to IPA while the following sessions are focusing on uploading you data or interpreting your results. Our experts Dr. Lynne Mullen and Dr. Jasmin Droege are hosting the webinars in U.S. and EU time zones, respectively.
You can find all our IPA support webinars here:
If you're interested in watching other webinars or videos, you can find our complete collection on tv.qiagenbioinformatics.com.
We're pleased to announce our partnership with Information Technology for Translational Medicine (ITTM). We have partnered to develop a prototype of a connector for transferring data from tranSMART to IPA for further analysis and back to tranSMART for visualization.
For more information about the connector and our partnership, please read the official press release from ITTM below.
Press release
ITTM and QIAGEN provide new tranSMART functionality
ITTM S.A. in partnership with QIAGEN
Boston, MA, April 6th, 2016
Information Technology for Translational Medicine, S.A. (ITTM S.A.) announced today that it has partnered with QIAGEN to develop the first prototype of a connector between tranSMART and Ingenuity Pathway Analysis (IPA®). The connector will be provided to the tranSMART Foundation to further strengthen the development of the tranSMART platform. tranSMART is a global open-source bio-medical knowledge management platform and the new application is available on the latest tranSMART version release 1.2.4.
Scientists who have access to both platforms will be able to transfer data from tranSMART to IPA® for further analysis. The results of the IPA Core Analysis are being transferred back to tranSMART for visualization. IPA® is a web-based software application for the analysis, integration, and interpretation of data derived from ‘omics experiments, such as RNAseq, small RNAseq, microarrays including miRNA and SNP, metabolomics, proteomics, and small- scale experiments that generate gene and chemical lists.
“We wanted to provide a flexible solution that fits the requirements of our pharma partners. We plan to further develop the prototype and to provide additional integration solutions for our customers in the future.” Dr. Andreas Kremer, Managing Director of ITTM S.A.
"This is a great example how one can use Ingenuity Pathway Analysis' programming interfaces to integrate our unique and best in class content and interpretation capabilities in pathway analysis and genomics into a knowledge ecosystem covering other areas of knowledge”, said Dr. Frank Schacherer, VP for QIAGEN Bioinformatics.” ITTM has proven to be an excellent partner for tranSMART integration and customization."
About ITTM S.A.
ITTM S.A. is a spin-off company of the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg. They provide data integration and knowledge management solutions and services to all bio-medical research areas. It focuses especially on translational medicine studies and clinical trials, in which heterogeneous data need to be curated, linked and integrated. ITTM S.A. offers cutting-edge clinical and multi-omics data analysis, visualization and text-mining solutions. For more information about ITTM, please visit the website at http://www.ittm-solutions.com.
About QIAGEN Redwood City
As QIAGEN’s Center of Excellence in Biological Analysis and Interpretation, QIAGEN Redwood, City (formerly Ingenuity Systems) is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems in life science research and molecular diagnostics. These innovative solutions offered by QIAGEN are used by tens of thousands of researchers and clinicians at hundreds of leading pharmaceutical, biotechnology, academic, diagnostic and clinical institutions worldwide. Further information can be found at https://digitalinsights.qiagen.com.
